name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
MP:0008670 decreased interleukin-12b secretion 20 4 18.2 8.12 5.8e-05 0.012 23.3 5.57 74.2
MP:0008668 abnormal interleukin-12b secretion 34 5 13.4 7.62 3.1e-05 0.012 16.2 4.81 43.6
MP:0008556 abnormal tumor necrosis factor secretion 233 11 4.29 5.37 4.7e-05 0.012 4.87 2.32 9.31
MP:0000240 extramedullary hematopoiesis 167 9 4.9 5.37 8.7e-05 0.012 5.52 2.4 11.2
MP:0001547 abnormal lipid level 1097 27 2.24 4.61 3.6e-05 0.012 2.73 1.68 4.31
MP:0002118 abnormal lipid homeostasis 1155 27 2.13 4.31 8.8e-05 0.012 2.57 1.58 4.06
MP:0002419 abnormal innate immunity 616 18 2.66 4.49 0.00011 0.014 3.07 1.73 5.2
MP:0008704 abnormal interleukin-6 secretion 183 9 4.47 5 0.00018 0.018 5.01 2.18 10.1
MP:0002451 abnormal macrophage physiology 427 14 2.98 4.42 0.00022 0.021 3.38 1.76 6.03
MP:0008560 increased tumor necrosis factor secretion 119 7 5.35 5.04 0.00032 0.027 5.96 2.28 13.2
MP:0008561 decreased tumor necrosis factor secretion 129 7 4.94 4.75 0.00053 0.04 5.47 2.1 12.1
MP:0008189 increased transitional stage B cell number 38 4 9.58 5.58 0.00076 0.045 11 2.77 31.6
MP:0005014 increased B cell number 318 11 3.15 4.11 0.00071 0.045 3.49 1.67 6.63
MP:0002429 abnormal blood cell morphology/development 1106 24 1.97 3.64 0.00073 0.045 2.3 1.39 3.7
MP:0008214 increased immature B cell number 68 5 6.69 4.96 0.00088 0.048 7.45 2.29 18.9
